An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

被引：1
|
作者：
Chen, Christine [1 ]
Paul, Harminder [1 ]
Del Rizzo, Luisa [1 ]
Le, Lisa W. [2 ]
Wei, Ellen Nong [1 ]
Lau, Anthea
Johnston, James B. [3 ]
Gibson, Spencer B. [3 ]
Brown, Michelle [3 ]
Trudel, Suzanne
机构：
[1] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada
[2] Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada
[3] Canc Care Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2895.2895
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2895
引用
收藏
页数：2
相关论文
共 50 条
  • [1] An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Le, Lisa W.
    Wei, Ellen Nong
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle L.
    Trudel, Suzanne
    BLOOD, 2015, 126 (23)
  • [2] A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Kakar, Sumeet
    Le, Lisa W.
    Wei, Ellen N.
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle
    Spaner, David
    Croucher, Danielle
    Sherry, Barbara
    Trudel, Suzanne
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 980 - 989
  • [3] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [4] A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Xu, Wei
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Leung-Hagensteijn, Chungyee
    BLOOD, 2008, 112 (11) : 23 - 23
  • [5] Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
    Kumar, Shaji K.
    Berdeja, Jesus G.
    Niesvizky, Ruben
    Lonial, Sagar
    Laubach, Jacob P.
    Hamadani, Mehdi
    Stewart, A. Keith
    Hari, Parameswaran
    Roy, Vivek
    Vescio, Robert
    Kaufman, Jonathan L.
    Berg, Deborah
    Liao, Eileen
    Di Bacco, Alessandra
    Estevam, Jose
    Gupta, Neeraj
    Hui, Ai-Min
    Rajkumar, Vincent
    Richardson, Paul G.
    LANCET ONCOLOGY, 2014, 15 (13): : 1503 - 1512
  • [6] Long-Term Follow-up of a Phase 2 Study of Single Agent Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Wang, Trina
    Le, Lisa W.
    Kukreti, Vishal
    Wei, Ellen Nong
    Lau, Anthea
    Bergsagel, P. Leif
    Dave, Nimisha
    Trudel, Suzanne
    BLOOD, 2012, 120 (21)
  • [7] a Phase 2 Study of Alemtuzumab-Ofatumumab (A plus O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Ma, Shuo
    Rosen, Steven T.
    Frankfurt, Olga
    Winter, Jane N.
    Kreutzer, Jennifer
    Husa, Sonja
    Otsterborg, Anders
    Lundin, Jeanette
    BLOOD, 2014, 124 (21)
  • [8] Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan
    Kiyohiko Hatake
    Michinori Ogura
    Kohichi Takada
    Masafumi Taniwaki
    Fanghong Zhang
    Taizo Fujita
    Kiyoshi Ando
    International Journal of Hematology, 2017, 106 : 240 - 247
  • [9] Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia
    Soumerai, Jacob D.
    Davids, Matthew S.
    Werner, Lillian
    Fisher, David C.
    Armand, Philippe
    Amrein, Philip C.
    Neuberg, Donna
    Hochberg, Ephraim P.
    Brown, Jennifer R.
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2931 - 2938
  • [10] Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan
    Hatake, Kiyohiko
    Ogura, Michinori
    Takada, Kohichi
    Taniwaki, Masafumi
    Zhang, Fanghong
    Fujita, Taizo
    Ando, Kiyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (02) : 240 - 247
12345